UTILIZATION OF THE SEQUENCE OF A GENETIC PROMOTER FOR THE TREATMENT OF RHEUMATIC DISEASES

摘要

An antagonistic inhibitor against mesenchymal cell growth, usable as a remedy for collagen diseases typified by rheumatoid arthritis and containing an AP-1 nucleotide comprising TGAGTCA or TGACTCA constituting a gene expression promoter.